Evaluating the consistency of differential expression of microRNA detected in human cancers

Molecular Cancer Therapeutics

Volumn 10, Issue 5, 2011, Pages 752-760

  Gong, Xue ^a   Wu, Ruihong ^a   Wang, Hongwei ^a   Guo, Xinwu ^a   Wang, Dong ^a,b   Gu, Yunyan ^a   Zhang, Yuannv ^a   Zhao, Wenyuan ^a   Cheng, Lixin ^a   Wang, Chenguang ^a   Guo, Zheng ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; COLON CANCER; DOWN REGULATION; HUMAN; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STOMACH CANCER; TUMOR GENE; UPREGULATION;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 79955997241     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-0837     Document Type: Article

References (49)

1. Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006;25:6163-9.
2. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009;10:704-14.
3. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-66.
4. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006;66:7390-4.
5. Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010;9:775-89.
6. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007;12:215-29.
7. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeuticoutcomeincolonadenocarcinoma.JAMA2008;299:425-36.
8. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 2009;9:401.
9. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-61.
10. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-46.
11. Gandellini P, Folini M, Zaffaroni N. Towards the definition of prostate cancer-related microRNAs: where are we now? Trends Mol Med 2009;15:381-90.
12. Marshall E. Getting the noise out of gene arrays. Science 2004;306:630-1.
13. Ransohoff DF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer 2004;4:309-14.
14. Ransohoff DF. Bias as a threat to the validity of cancer molecularmarker research. Nat Rev Cancer 2005;5:142-9.
15. Ein-Dor L, Kela I, Getz G, Givol D, Domany E. Outcome signature genes in breast cancer: is there a unique set?Bioinformatics 2005;21:171-8.
16. Zhang M, Zhang L, Zou J, Yao C, Xiao H, Liu Q, et al. Evaluating reproducibility of differential expression discoveries in microarray studies by considering correlated molecular changes. Bioinformatics 2009;25:1662-8.
17. Yao C, Li H, Zhou C, Zhang L, Zou J, Guo Z. Multi-level reproducibility of signature hubs in human interactome for breast cancer metastasis. BMC Syst Biol 2010;4:151.
18. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
19. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006;439:353-7.
20. Ivanovska I, Cleary MA. Combinatorial microRNAs: working together to make a difference. Cell Cycle 2008;7:3137-42.
21. Dalmay T, Edwards DR. MicroRNAs and the hallmarks of cancer. Oncogene 2006;25:6170-5.
22. Osada H, Takahashi T. MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 2007;28:2-12.
23. Yang D, Li Y, Xiao H, Liu Q, Zhang M, Zhu J, et al. Gaining confidence in biological interpretation of the microarray data: the functional consistence of the significant GO categories. Bioinformatics 2008;24:265-71.
24. Gong X, Wu R, Zhang Y, Zhao W, Cheng L, Gu Y, et al. Extracting consistent knowledge from highly inconsistent cancer gene data sources. BMC Bioinformatics 2010;11:76.
25. Wang D, Wang C, Zhang L, Xiao H, Shen X, Ren L, et al. Evaluation of cDNA microarray data by multiple clones mapping to the same transcript. Omics 2009;13:493-9.
26. Zhang M, Yao C, Guo Z, Zou J, Zhang L, Xiao H, et al. Apparently low reproducibility of true differential expression discoveries in microarray studies. Bioinformatics 2008;24:2057-63.
27. Jiang Q, Hao Y, Wang G, Juan L, Zhang T, Teng M, et al. Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Syst Biol 2010;4 Suppl 1:S2.
28. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are micro- RNA targets. Cell 2005;120:15-20.
29. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008;36:D149-53.
30. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37:495-500.
31. Creighton CJ, Nagaraja AK, Hanash SM, Matzuk MM, Gunaratne PH. A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA 2008;14:2290-6.
32. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, et al. Missing value estimation methods for DNA microarrays. Bioinformatics 2001;17:520-5.
33. Pradervand S, Weber J, Thomas J, Bueno M, Wirapati P, Lefort K, et al. Impact of normalization on miRNA microarray expression profiling. Rna 2009;15:493-501.
34. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006;34:D140-4.
35. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 1995;57:289-300.
36. Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci U S A 2006;103:5923-8.
37. Irizarry RA, Warren D, Spencer F, Kim IF, Biswal S, Frank BC, et al. Multiple-laboratory comparison of microarray platforms. Nat Methods 2005;2:345-50.
38. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27-30.
39. Pan W, Lin J, Le CT. How many replicates of arrays are required to detect gene expression changes in microarray experiments? A mixture model approach. Genome Biol 2002;3:RESEARCH 0022.
40. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008;68:6162-70.
41. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, et al. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 2009;16:206-16.
42. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008;455:64-71.
43. Makeyev EV, Maniatis T. Multilevel regulation of gene expression by microRNAs. Science 2008;319:1789-90.
44. Joung JG, Fei Z. Computational identification of condition-specific miRNA targets based on gene expression profiles and sequence information. BMC Bioinformatics 2009;10 Suppl 1:S34.
45. Liu B, Li J, Tsykin A. Discovery of functional miRNA-mRNA regulatory modules with computational methods. J Biomed Inform 2009;42:685-91.
46. Liu H, Kohane IS. Tissue and process specific microRNA-mRNA coexpression in mammalian development and malignancy. PLoS One 2009;4:e5436.
47. Bandyopadhyay S, Mitra R, Maulik U, Zhang MQ. Development of the human cancer microRNA network. Silence 2010;1:6.
48. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-47.
49. Zhang S, Chen L, Jung EJ, Calin GA. Targeting microRNAs with small molecules: from dream to reality. Clin Pharmacol Ther 2010;87:754-8.